Navigation Links
Flagship Biosciences Hires New Vice President of Clinical Diagnostics
Date:4/1/2020

Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years of experience in developing and commercializing diagnostic tests and medical devices. In his new role, Geoff will lead the creation and implementation of diagnostic tissue tests utilizing Flagship’s unique tissue analysis technology, workflow, and CAP/CLIA lab.

Geoff has served in a variety of leadership roles from strategic planning and product development to sales and marketing and business development. His background includes successes with industry leaders Eli Lilly, Siemens, and Beckman Coulter, and most recently with start-up organizations, creating businesses based on novel technologies. Geoff earned a BS in Chemical Engineering from Virginia Tech and an MBA from Harvard University.

“It’s my pleasure to welcome Geoff to the Flagship family,” said Trevor Johnson, Flagship Biosciences CEO. “Geoff’s broad industry experience and specifically in preparing and marketing diagnostic tests make him the perfect new leader for our growing clinical diagnostics business unit.”

Flagship already supports diagnostic labs, cancer centers, and academic medical centers with tissue data insights gained in its College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified lab. Geoff will expand these offerings for clinical clients and partners.

“I couldn’t be happier about joining Flagship to expand clinical diagnostics,” said Geoff. “Flagship clients already benefit from the company’s scientific process enhanced by machine learning, and from its laboratory capabilities and tissue analysis technology. I’m excited to build on this strong foundation to bring new diagnostic tissue tests to market.”

About Flagship Biosciences
Founded in 2009 and headquartered in Westminster, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available. It is revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Flagship’s services and technology dramatically improve on the data and interpretation from traditional pathology methods, eliminating variability and bringing new insights to tissue analysis results. With expert scientific consultation on every project, Flagship’s team interprets results, contextualizes tissue biology, and identifies the best course for success. flagshipbio.com

Read the full story at https://www.prweb.com/releases/flagship_biosciences_hires_new_vice_president_of_clinical_diagnostics/prweb17014196.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Flagship US Arctic research facility welcomes EU scientists
2. Huge new influx of Graphene Flagship partners
3. FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM
4. FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM
5. Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomis Latest Flagship Smartphones
6. Synaptics Brings Natural ID Technology to Sharps Newest Flagship Smartphone
7. Synaptics Delivers Touch Controller Solutions to Googles Latest Flagship Nexus Smartphones
8. Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services
9. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
10. Inflection Biosciences licenses preclinical oncology programs from the CNIO
11. Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary report by ... 2019 average medical sales rep total compensation increased by $12,000 over the previous ... COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet again there’s ...
(Date:5/1/2020)... , ... April 30, 2020 , ... ... announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. ... and companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to ...
(Date:4/30/2020)... ... April 29, 2020 , ... At ... growth – delivering innovative solutions for a wide range of industries including pharmaceutical ... agencies. A month into the new decade, it was clear to company leadership ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce ... and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. , This ... United States, linking US and Asia Pacific healthcare innovators with capital and investors. , ...
(Date:5/15/2020)... , ... May 15, 2020 , ... Sentien Biotechnologies, Inc., ... of Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s ... well as work closely with CEO Brian Miller and Sentien’s management team. ...
(Date:5/9/2020)... ... ... Worldwide Business with kathy ireland® will be LIVE streaming ... Wednesday, May 13, 2020 at 8:00pm ET / PT – prime time viewings ... Techolution and Bravado Pharmaceuticals . , As leaders in their industries, ...
(Date:4/26/2020)... ... 2020 , ... Indegene Omnipresence, Inc. announced the launch of ... for use on Microsoft Azure. The customer experience management (CXM) technology allows life ... built-for-purpose customer engagement capability to use in their commercial or medical operations. ...
Breaking Biology Technology: